{"entity":{"id":"nct02792465","kind":"trial","name":"A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of CFI-402257 run by University Health Network, Toronto, completed.","summary":"A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT02792465 by University Health Network, Toronto, with 52 participants enrolled, started 2016-11-11. Conditions recorded: Advanced Solid Cancers and Breast Cancer. Interventions recorded: CFI-402257 and Fulvestrant.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT02792465","url":"https://clinicaltrials.gov/study/NCT02792465"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer","breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["cfi-402257"],"companies":["treadwell-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02792465","phase":"1","setting":"An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-402257 Administered Orally to Patients With Advanced Solid Tumors","sponsor":"University Health Network, Toronto","enrolled":52,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02792465/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"},{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"cfi-402257","kind":"drug","name":"CFI-402257","route":"/drugs/cfi-402257/"}],"company":[{"id":"treadwell-therapeutics","kind":"company","name":"Treadwell Therapeutics","route":"/companies/treadwell-therapeutics/"}]}}